BioSpace · 1 day ago
2025 Quantitative, Translational, and ADME Sciences (QTAS) MS Proteomics Intern
Maximize your interview chances
BiotechnologyCommunities
Comp. & Benefits
Insider Connection @BioSpace
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Identify and optimize suitable MAPPs technologies that can be onboarded and developed internally.
Collaborate with the preclinical safety team to fully understand the assay needs and limitations of their sample matrix.
Plan and execute pilot and actual MAPPs studies to generate a list of MHC-II-associated peptides that may activate T cells in a tested donor, and report results to the preclinical safety team.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Currently enrolled in university, pursuing a PhD in Immunology, Oncology, Biochemistry, or other related field.
Must be enrolled in university for at least one semester following the internship.
Proficiency in MS proteomics workflow: sample preparation, design, and execution.
Broad knowledge of mass spectrometry instrumentation, including but not limited to operation and maintaining orbitraps and/or time-of-flight mass spectrometers.
Preferred
Expected graduation date between December 2025 July 2026.
Exposure to the immunopeptidomics field, preferably in the context of immunogenicity.
Extensive experience in designing and executing sensitive MAPPs or other global MS proteomics sample preparation protocols.
Familiarity with cross-team collaborations and ability to clearly communicate advantages and challenges associated with sensitive sample preparation protocols.
Excellent communication and presentation skills and a strong team spirit.
Benefits
Competitive pay.
Relocation support for eligible students.
Select wellness benefits and paid holiday / sick time.
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
Crunchbase News
2024-11-20
2024-05-31
Company data provided by crunchbase